Tag Archives: ACOs

Physicians Won’t Change Their Practices Without Worthwhile Incentives

By Mark Wagar. (This blog first appeared on Managed Healthcare Executive.) There is more collaboration than ever between payers and providers in the drive to provide high-quality, cost-effective care to diverse populations across the United States. According to a January 2014 Centers for Medicare and Medicaid Services (CMS) report, the accountable care organization (ACO) model is […]
Posted in Guest Blog, healthcare, Regulatory | Also tagged , , , , , | Leave a comment

Physicians in ACOs Dare Pharma to Step up Its Game

Pharma, according to physicians currently embedded within Accountable Care Organizations (ACOs), is not living up to its potential. A survey conducted by Oliver Wyman has most of its 200 respondents saying the industry could play a more active role with value-based healthcare providers in helping to deliver better care at a lower cost, but it […]
Posted in healthcare, Strategy | Also tagged , , , | Leave a comment

Obamacare After Nov 6th: Trouble for Pharma?

by Tom Norton No doubt the November 6th election is going to be close, very close: close for the Presidency, close for the Senate, and possibly close for the House.  So close, in fact, it’s possible that no substantial political change will occur in Washington, as a result. That said, for the U.S. pharmaceutical industry […]
Posted in Events, FDA, leadership, Legal, Market Access, pricing, R&D, Regulatory | Also tagged , , , | 3 Comments

Show Me the Money: Exploring Physician Incentive Compensation

A new report from ZS Associates explores the efficacy and impact of physician incentive compensation on the delivery of quality care; when incentives fall short, so can patient outcomes.
Posted in Op-Ed, Strategy | Also tagged , | 1 Comment
  • Categories

  • Meta